The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Pato, M. T.
* Articles by Murphy, D. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Pato, M. T.
* Articles by Murphy, D. L.

Am J Psychiatry 1988; 145:1521-1525
Copyright © 1988 by American Psychiatric Association


REGULAR ARTICLES

Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder

MT Pato, R Zohar-Kadouch, J Zohar and DL Murphy
Laboratory of Clinical Science, NIMH, Bethesda, MD 20892.

To evaluate the need for maintenance drug therapy in patients with obsessive-compulsive disorder, the authors assessed 21 patients with obsessive-compulsive disorder who manifested sustained improvement during 5 to 27 months of clomipramine treatment and who agreed to participate in a double-blind discontinuation study. Of 18 patients who completed the study, 16 had substantial recurrence of obsessive- compulsive symptoms by the end of the 7-week placebo period. In addition, 11 had a significant increase in depressive symptoms. Treatment duration before discontinuation of clomipramine was not related to the frequency or severity of obsessive-compulsive or depressive symptom appearance. These findings suggest that prolonged drug treatment may be warranted for obsessive-compulsive disorder.


This article has been cited by other articles:


Home page
FocusHome page
J. H. Greist and J. W. Jefferson
Obsessive-Compulsive Disorder
Focus, January 1, 2007; 5(3): 283 - 298.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
L. M. Koran M.D.
Obsessive-Compulsive Disorder: An Update for the Clinician
Focus, January 1, 2007; 5(3): 299 - 313.
[Full Text] [PDF]


Home page
FocusHome page
K. A. Kobak, J. H. Greist, J. W. Jefferson, D. J. Katzelnick, and H. J. Henk
Behavioral Versus Pharmacological Treatments of Obsessive Compulsive Disorder: A Meta-Analysis
Focus, July 1, 2004; 2(3): 462 - 474.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. A. Jenike
Obsessive-Compulsive Disorder
N. Engl. J. Med., January 15, 2004; 350(3): 259 - 265.
[Full Text] [PDF]


Home page
DTBHome page
Selective serotonin reuptake inhibitors in obsessive-compulsive disorder
DTB, June 1, 1995; 33(6): 47 - 48.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. Greist, G. Chouinard, E. DuBoff, A. Halaris, S. W. Kim, L. Koran, M. Liebowitz, R. B. Lydiard, S. Rasmussen, K. White, et al.
Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive Disorder
Arch Gen Psychiatry, April 1, 1995; 52(4): 289 - 295.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. h. Greist, J. W. Jefferson, K. A. Kobak, D. J. Katzelnick, and R. C. Serlin
Efficacy and Tolerability of Serotonin Transport Inhibitors in Obsessive-compulsive Disorder: A Meta-analysis
Arch Gen Psychiatry, January 1, 1995; 52(1): 53 - 60.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
H. L. Leonard, S. E. Swedo, M. C. Lenane, D. C. Rettew, S. D. Hamburger, J. J. Bartko, and J. L. Rapoport
A 2- to 7-Year Follow-up Study of 54 Obsessive-Compulsive Children and Adolescents
Arch Gen Psychiatry, June 1, 1993; 50(6): 429 - 439.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
H. L. Leonard, S. E. Swedo, M. C. Lenane, D. C. Rettew, D. L. Cheslow, S. D. Hamburger, and J. L. Rapoport
A Double-blind Desipramine Substitution During Long-term Clomipramine Treatment in Children and Adolescents With Obsessive-Compulsive Disorder
Arch Gen Psychiatry, October 1, 1991; 48(10): 922 - 927.
[Abstract] [PDF]


Home page
Behav ModifHome page
B. A. Thyer
Diagnosis and Treatment of Child and Adolescent Anxiety Disorders
Behav Modif, July 1, 1991; 15(3): 310 - 325.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
T. A. Pigott, M. T. Pato, S. E. Bernstein, G. N. Grover, J. L. Hill, T. J. Tolliver, and D. L. Murphy
Controlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive Disorder: Behavioral and Biological Results
Arch Gen Psychiatry, October 1, 1990; 47(10): 926 - 932.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1988 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org